Strike Pharma
SwedenEntry
2022
Hold
4yr
Status
Active
Who owns Strike Pharma?
Strike Pharma is a Swedish Biotech company, currently owned by Flerie since 2022 and 2 other investors.
Hand-verified · updated 2026-08-17
Open JSON · CC-BY
Most recent investor
Eir VenturesEir Ventures I · 2020 · Life Sciences VC
3 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusActive
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2021 · present
Almi InvestActive
2021 · present(5yr) · Almi Invest (Regional funds) · 2009 · VC
Eir VenturesActive
2022 · present(4yr) · Eir Ventures I · 2020 · Life Sciences VC
FlerieActive
2022 · present(4yr) · Flerie Invest · 2011 · Life Sciences VC
More from Eir Ventures I
Other portfolio companies in the same fund.
Denmark
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Strike Pharma?
Strike Pharma is currently owned by Flerie, Eir Ventures and 1 other, through Eir Ventures I, since 2022.
When did Flerie and 2 others acquire Strike Pharma?
Flerie and 2 others acquired Strike Pharma in 2022.
Who has owned Strike Pharma over time?
Strike Pharma has been through 3 private-equity ownership periods: Almi Invest · via Almi Invest (Regional funds) · since 2021; Flerie · via Flerie Invest · since 2022; Eir Ventures · via Eir Ventures I · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue